Results 171 to 180 of about 104,921 (341)
Botulinum toxin type A for the management of glabellar rhytids
Clinical, Cosmetic and Investigational Dermatology, 2010 Anne Marie Tremaine, Jerry L McCulloughDepartment of Dermatology, University of California, Irvine, CA, USAAbstract: There is an increasing demand for minimally-invasive cosmetic procedures to arrest the aging process.
Anne Marie Tremaine, Jerry L McCullough
doaj
Molecular composition of Clostridium botulinum type A progenitor toxins [PDF]
, 1996 Kaoru Inoue +8 more
openalex +1 more source
Equine Veterinary Journal, EarlyView.Abstract Botulism is a severe and often fatal disease in equine patients worldwide. Clostridium botulinum is a ubiquitous soil organism which produces a potent neurotoxin resulting in neuromuscular blockade and flaccid paralysis in affected animals. Definitive diagnosis is often impractical or impossible, leading to diagnosis and treatment based on ...
Kali Slavik +2 more
wiley +1 more source
Role of Botulinum Toxin A in Cerebral Palsy – 10yrs Experience
, 2017 PA Mohammed Kunju
openalex +1 more source
Therapeutic effect of Botulinum toxin-A in 88 patients with Trigeminal Neuralgia with 14-month follow-up [PDF]
, 2014 Shuang Li +9 more
openalex +1 more source
A guide to the types, structures, and multifaceted functions of matrix metalloproteinases in cancer
The FEBS Journal, EarlyView.Matrix metalloproteinases (MMPs) orchestrate cancer progression and metastasis through proteolytic and non‐proteolytic actions. By remodeling the tumor microenvironment, enhancing growth factor availability, and modulating cell behavior, MMPs promote proliferation, migration or invasion, and epithelial‐to‐mesenchymal transition. Alongside extracellular
Zoi Piperigkou +4 more
wiley +1 more source
Efficacy and safety of Botulinum toxin A for improving esthetics in facial complex: A systematic review [PDF]
, 2021 Ritu Gangigatti +4 more
openalex +1 more source
Headache: The Journal of Head and Face Pain, EarlyView.Abstract Objective This study assesses the 3‐month effectiveness of the calcitonin gene‐related peptide monoclonal antibody galcanezumab versus traditional oral migraine preventive medications. Background Studies comparing the effectiveness of calcitonin gene‐related peptide monoclonal antibodies versus traditional oral migraine preventive medications ...
Richard B. Lipton +7 more
wiley +1 more source
Combination therapy with botulinum toxin and bulking agent—An efficient, sustainable, and safe method to treat elderly women with mixed urinary incontinence [PDF]
, 2021 Volker Viereck +5 more
openalex +1 more source